Anavex Life Sciences Corp (AVXL)

[Anshu2]

Exactly.

CM claims ORs to be the endpoint measures based on SAP, in response to Sumit’s Q post CTAD call in 12/22.

Now, he is instead claiming success based on LSM (sidelining ORs).

Neither of them was ever comminuted by CM before 12/22. Neither of them is the standard measure of change in mean — that the whole world uses.

Of course, the flip-flop is not relevant to the NDA or FDA. But just shows that he’s playing a sleazy game with the market and investors. And, the market is punishing.